Emergent Biosolutions, Inc. (EBS): Price and Financial Metrics

EBS POWR Grades

• EBS scores best on the Value dimension, with a Value rank ahead of 99.48% of US stocks.
• The strongest trend for EBS is in Momentum, which has been heading down over the past 179 days.
• EBS's current lowest rank is in the Momentum metric (where it is better than 8.18% of US stocks).

EBS Stock Summary

• EBS's current price/earnings ratio is 9.61, which is higher than only 24.06% of US stocks with positive earnings.
• Price to trailing twelve month operating cash flow for EBS is currently 6.91, higher than 26.16% of US stocks with positive operating cash flow.
• Emergent BioSolutions Inc's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is 5.68%, greater than the shareholder yield of 75.08% of stocks in our set.
• Stocks with similar financial metrics, market capitalization, and price volatility to Emergent BioSolutions Inc are CSGS, MDRX, RNWK, SPOK, and ONTO.
• Visit EBS's SEC page to see the company's official filings. To visit the company's web site, go to www.emergentbiosolutions.com.

EBS Valuation Summary

• In comparison to the median Healthcare stock, EBS's price/sales ratio is 82.38% lower, now standing at 2.
• Over the past 180 months, EBS's price/sales ratio has gone down 0.9.
• EBS's EV/EBIT ratio has moved down 34.7 over the prior 180 months.

Below are key valuation metrics over time for EBS.

EBS Growth Metrics

The 3 year price growth rate now stands at 24.49%.
• Its 4 year revenue growth rate is now at 94.3%.
• Its 5 year price growth rate is now at 105.48%.

Over the past 34 months, EBS's revenue has gone up $937,514,000.

The table below shows EBS's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-12-31	1,792.7	321.1	230.9
2021-09-30	1,652.5	237.2	227
2021-06-30	1,708.7	325.7	299.2
2021-03-31	1,705.9	483.3	387.3
2020-12-31	1,555.4	536	305.1
2020-09-30	1,332.7	413	166.6

EBS's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• EBS has a Quality Grade of C, ranking ahead of 50.38% of graded US stocks.
• EBS's asset turnover comes in at 0.604 -- ranking 57th of 681 Pharmaceutical Products stocks.
• ARWR, IBIO, and MCRB are the stocks whose asset turnover ratios are most correlated with EBS.

The table below shows EBS's key quality metrics over time.